Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy

Hepato-Gastroenterology

Volumn 43, Issue 12, 1996, Pages 1557-1561

  Van Thiel, David H ^a   Friedlander, Lois ^b   Molloy, Peter J ^b   Kania, Robert J ^b   Fagiuoli, Stefano ^b   Wright, Harlan I ^b   Gasbarrini, Antonio ^b   Caraceni, Paolo ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NONE

Author keywords

HCV; IFN non response; Interferon; Iron; Iron reduction therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEMOGLOBIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PHLEBOTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030471382     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha. N Engl J Med 1989;321:1501-1506.
2. DiBisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med; 1989; 321:1506-1510.
3. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou JP. Recombinant human a-interferon in patients with chronic non-A, non-B hepatitis: A multi-center randomized controlled trial from France. Hepatology 1991;13:393-397.
4. Silva M, Kuhns M, Laverne J, Jeffers L, Reddy R, Parker T, McNamara A, Carney L, Alvarez L, Roach K, de Medina M, Schiff ER. Long-term remission of chronic hepatitis C after interferon (IFN) therapy: Virologic, histologic and biochemical features. Gastroenterology 1992;102:A888.
5. Realdi G, Diodati G, Bonetti P, Scaccabarozzi S, Alberti A, Ruol A. Recombinant human interferon alfa-2a in community- acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial. J Hepatol 1990;11(Suppl 1):568-571.
6. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986;315:1575-1578.
7. Van Thiel DH, Friedlander L, Fagivoli S, Wright HI, et al. Response to interferon a therapy is influenced by the iron content of the liver. J Hepatology 1994; 20: 410-415.
8. Olynyk J, Reddy R, Di Bisceglie AM, Jeffers LJ, Parker T, Radick J, Schiff ER, Bacon BR. Hepatic Iron Concentration as a Predictor of Response to Alpha Interferon Therapy in Chronic Hepatitis C. Hepatology 1993;18:90A.
9. Bacon BR, Rebholz AE, Fried M, Di Bisceglie AM. Beneficial Effect of Iron Reduction Therapy in Patients with Chronic Hepatitis C Who Failed to Respond to Interferon-a. Hepatology 1993;18:150A.
10. Barton A, Cable E, Smith L, Banner B, Bonkovsky H. Distribution of Iron in the Liver Predicts the Response of Chronic Hepatitis C Infection to Interferon Therapy. Hepatology 1993;18:150A.
11. Sutnic AI, Blumberg BS, Lustbader ED. Alleviated Serum Iron Levels and Persistent Australia Antigen (HBsAg). Ann Int Med 1974;81:855-856.
12. Lustbader ED, Hann H-WL, Blumberg BS. Serum Ferritin as a Predictor of Host Response to Hepatitis B Virus Infection. Science 1983;220:423-425.
13. Blumberg BS, Lustbader ED, Whitford PL. Changes in Serum Iron Levels Due to Infection with Hepatitis B Virus. Proc Natl Acad Sci 1981;78:3222-3224.
14. Fargion S, Paperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 1992;16:1322-1326.
15. Kemp JD. The role of iron and iron binding proteins in lymphocyte physiology and pathology. J Clin Immunol 1993;13:81-92.
16. Borysiewicz LK, Graham S, Sissons JGP. Human natural killer cells lysis of virus infected cells: relationship to expression of the transferrin receptor. Eur J Immunol 1986;16:405-511.